Bartolucci L, Canini F, Fioroni E, Pinchi G, Carosi M
Minerva Med. 1981 Feb 28;72(7):325-32.
In 40 patients with bronchopulmonary diseases, in prevalence of chronic type, the therapeutic value of a new antiphlogistic-balsamic compound was evaluated. The favourable results obtained, particularly as far as the rapidity of regression of signs and symptoms is concerned, showed that this drug may have a significant role in a combined scheme of treatment.
在40例以慢性类型为主的支气管肺部疾病患者中，评估了一种新型消炎镇痛复方制剂的治疗价值。所获得的良好结果，尤其是在症状和体征消退的速度方面，表明该药物在联合治疗方案中可能具有重要作用。
